Some technological and policy strategies for increasing organ supplies are ethically and legally proven to work. Consider best next steps for global education efforts to raise organ donation awareness.

Because transplantation for methylmalonic acidaemia prioritizes quality of life over long-term outcomes, justice and utility must be considered.

Equal access is a goal even when patients present with taboo illnesses. But, the date of a patient’s last drink still matters.

If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.

Law doesn’t always adequately address unauthorized uses of individuals’ DNA. Ethics can help establish legal privacy protections that work.

Dr Charles Binkley joins Ethics Talk to discuss his article, coauthored with Michael Politz and Dr Brian Green: "Who, If Not the FDA, Should Regulate Implantable Brain-Computer Interface Devices?"

Standards for posttransplant graft/survival rates do not reward transplant centers for performing riskier transplants to increase population benefit.

Recent advances in UTx suggest it is on a trajectory toward becoming an accepted clinical practice to treat absolute uterine factor infertility.

Transnational monitoring efforts should focus on safety, defining standard of care, and promoting just access to innovation.

Dichotomies, such as reconstructive vs aesthetic surgery and medical vs cosmetic dermatology, can distort meanings of surgical procedures. This can compromise the value of procedures themselves and practices for their reimbursement.